Effects of hydroxy pentacyclic triterpene acids from Forsythia viridissima on asthmatic responses to ovalbumin challenge in conscious guinea pigs

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 2, 2010, Pages 230-237

  Lee, Ji Yun ^a   Moon, Hee ^a   Kim, Chang Jong ^a  

^a Chung Ang University   (South Korea)

Author keywords

Anti asthmatic; Forsythia viridissima; Histamine; Phospholipase A2; Specific airway resistance; Triterpene acid

Indexed keywords

ACETIC ACID ETHYL ESTER; BETULIC ACID; CROMOGLYCATE DISODIUM; DEXAMETHASONE; EOSINOPHIL PEROXIDASE; HISTAMINE; HYDROXY PENTACYCLIC TRITERPENE ACID; OLEANOLIC ACID; OVALBUMIN; PHOSPHOLIPASE A2; SALBUTAMOL; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; URSOLIC ACID;

AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONSCIOUSNESS; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFECT; ENZYME ACTIVITY; EOSINOPHIL; FORSYTHIA; FORSYTHIA VIRIDISSIMA; GUINEA PIG; HISTOPATHOLOGY; LATENT PERIOD; LEUKOCYTE; LUNG LAVAGE; MALE; MEDIATOR; NEUTROPHIL; NONHUMAN; PATHOLOGY; PLETHYSMOGRAPH;

AIRWAY RESISTANCE; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CONSCIOUSNESS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSYTHIA; GUINEA PIGS; MALE; OVALBUMIN; PENTANOLS; PLANT EXTRACTS; TRITERPENES;

EID: 76049092244     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.230     Document Type: Article

References (26)

1. Hanania N. A., Chest, 133, 989-998 (2008).
2. Banner K. H., Marchini F., Buschi A., Moriggi E., Semeraro C., Page C. P., Pulm. Pharmacol., 8, 37-42 (1995).
3. Barnes P. J., Trends Mol. Med., 12, 515-520 (2006).
4. Nauta A. J., Fredi Engels F., Knipples L. M., Garssen J., Nijkamp F. P., Redegeld F. A., Eur. J. Pharmacol., 585, 354-360 (2008).
5. Crompton G., Prim. Care Respir. J., 15, 326-331 (2006).
6. Nishibe S., Chiba M., Hisada S., Yakugaku Zasshi, 97, 1134-1137 (1977).
7. Chiba M., Hisada S., Nishibe S., Shoyakugaku Zasshi, 32, 194-197 (1978).
8. Lee J. S., Min B. S., Bae K. W., Yakhak Hoeji, 40, 462-467 (1996).
9. Kang H. S., Lee J. Y., Kim C. J., J. Ethnopharmacol., 116, 305-312 (2008).
10. Jung C. H., Lee J. Y., Cho C. H., and Kim C. J., Arch. Pharm. Res., 30, 1599-1607 (2007).
11. Pennock B. E., Pennock C. P., Rogers R. M., Cain W. A., and Wells J. H., J. Appl. Physiol., 46, 399-406 (1979).
12. Sanjar S., Aoki S., Kristersson S. D., Moley J., Br. J. Pharmacol., 99, 679-686 (1990).
13. Aguirre M. C., Delporte C., Backhouse N., Erazo S., Letelier M. E., Cassels B. K., Silva X., Alegria S., Negrete R., Bioorg. Med. Chem., 14, 5673-5677 (2006).
14. Manoharan K. P., Song F. J., Benny T. K., Yang D., Magn. Reson. Chem., 45, 279-281 (2007).
15. Turkmen Z., Klymchenko A. S., Oncul S., Duportail G., Topcu G., Demchenko A. P., J. Biochem. Biophys. Methods, 64, 1-18 (2005).
16. Gua J. Q., Franzblau S. G., Montenegro G., Timmermann B. N., Z. Naturforrsch. C, 59, 797-802 (2004).
17. Galgon T. H., Höke D., Dräger B., Phytochem. Anal., 10, 187-190 (1999).
18. Shore P. A., Burkhalter A., Cohn V. H. Jr., J. Pharmacol. Exp. Ther., 127, 182-186 (1959).
19. Radvanyi F., Jordan L., Russo-Marie F., Bon C., Anal. Biochem., 177, 103-109 (1989).
20. Strath M., Warren D. J., Sanderson C. J., J. Immunol. Methods, 83, 209-215 (1985).
21. Richard V. N., Griffin R. L., Oosteen J. A., Morris J., Wiska D. G., Dunn C. J., Am. Rev. Respir. Dis., 140, 1712-1718 (1989).
22. Matsumoto T., Ashida Y., Tsukuda R., J. Pharmacol. Exp. Ther., 269, 1236-1244 (1994).
23. Kane G. C., Tollino M., Pollice M., Kim C. J., Cohn J., Murray J. J., Dworski R., Sheller J., Fish J. E., Peters S. P., Prostaglandins, 50, 1-18 (1995).
24. Kim M. S., Na H. J., Han S. W., Jin J. S., Song U. Y., Lee E. J., Song B. K., Kim H. M., Inflammation, 27, 129-135 (2003).
25. Dzubak P., Hajduch M., Vydra D., Hustova A., Kvasnica M., Biedermann D., Markova L., Urban M., Sarek J., Nat. Prod. Rep., 23, 394-411 (2006).
26. Svendsen U. G., Frølund L., Madsen F., Nielsen N. H., Holstein-Rathlou N. H., Weeke B. J., Allergy Clin. Immunol., 80, 68-74 (1987).